Rein Therapeutics, Inc. (RNTX) — Total Liabilities

Annual figures by fiscal year, from SEC filings.

2016: $4.08M2017: $4.89M2018: $10.71M2019: $10.43M2020: $4.18M2021: $4.58M2022: $3.38M2023: $7.71M2024: $7.80M2025: $7.24M$7.24M
2016Total Liabilities (USD)2025
Fiscal YearTotal LiabilitiesChange YoY
2025$7.24M-7.2%
2024$7.80M+1.1%
2023$7.71M+127.9%
2022$3.38M-26.1%
2021$4.58M+9.5%
2020$4.18M-59.9%
2019$10.43M-2.7%
2018$10.71M+119.0%
2017$4.89M+19.8%
2016$4.08M